People with Parkinson’s disease may experience a range of movement-related symptoms, such as tremors, slow movement, stiffness and balance problems. Wiesman hopes that a better understanding of how ...

Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa ...

Simon Fraser University researchers are pioneering personalized Parkinson's treatment using MEG imaging. They discovered that ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

Many have heard about Parkinson's Disease. Few know about the disorder and its impact. Even fewer people know how to manage ...

SUNRISE-PD is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled trial with a hybrid decentralized design that will last 20 weeks from the initial screening phase to the safety ...

Abstract Abstract. Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is associated with the development of motor complications.